Table 5 Summary of subgroups in the diagnosis categories
From: Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study
Number | Percent | Mean CSF leukocytes/μl | |
|---|---|---|---|
CNS infection | 106 | 40.5 | 1135.5 |
Meningitis. viral/unknown agent | 38 | 35.9 | 617.0 |
Meningitis. acute bacterial | 21 | 19.8 | 3591.3 |
Meningitis. borrelia/syphilis | 25 | 23.6 | 150.6 |
Encephalitis. infectious | 11 | 10.4 | 295.3 |
CNS abscess | 3 | 2.8 | 4654.3 |
Other CNS infection (Including: Herpes zoster with other complication in CNS, Hydrocephalus caused by infectious or parasitic disease classified elsewhere, Meningoencephalitis due to toxoplasmosis, Polyneuropathy caused by infectious or parasitic disease classified elsewhere, Viral infection of CNS unspecified) | 8 | 7.6 | 66.0 |
Infection outside CNS | 20 | 7.6 | 25.0 |
Endocarditis | 2 | 9.5 | 113.5 |
Sepsis | 10 | 47.6 | 18.8 |
Other infection with foci outside CNS (including: Acute pharyngitis, Acute sinusitis, Analabsces, Other pneumonia due to other unspecified microorganism, Oral candidiasis, HIV with other infectious and parasitic disease, Erysiphelas, unspecified, Viralinfection, unspecified, Pilonidal cyst with abscess) | 8 | 40.0 | 10.6 |
Non-infectious neurological diseases | 79 | 30.2 | 63.2 |
Encephalitis/myelitis. Non-infectious | 12 | 15.2 | 108.3 |
Seizures/epilepsy/status epilepticus | 6 | 7.6 | 15.8 |
Ischemia/infarction/stroke | 11 | 13.9 | 38.9 |
Intracranial haemorrhage | 2 | 2.5 | 85.0 |
Multiple sclerosis | 15 | 19.0 | 15.0 |
Demyelinating disease/polyneuropathy | 5 | 6.3 | 10.8 |
Paralysis/palsy of cranial nerve | 3 | 3.8 | 29.7 |
Headache/migraine | 5 | 6.3 | 10.2 |
Other neurological (including: Acute transverse myelitis in demyelinating disease of central nervous system, Other extrapyramidal and movement disorders, Ventriculitis of the brain, unspecified, Sequelae of inflammatory diseases of central nervous system), Obstructive hydrocephalus, Spinal stenosis, Herniation of lumbar disc with radiculopathy, Disorder of central nervous system, unspecified, Symptom of central nervous system unspecified) | 20 | 25.3 | 129.1 |
Malignancy. all foci | 23 | 8.8 | 119.7 |
Lymphoma | 9 | 39.13 | 20.7 |
Leukaemia | 3 | 13.04 | 16.3 |
CNS cancer | 5 | 21.74 | 30.6 |
Cancer. foci elsewhere (Including: Malignant neoplasm of unspecified part of unspecified bronchus or lung, Malignant neoplasm of oropharynx, unspecified, Agranulocytosis secondary to cancer chemotherapy) | 4 | 17.39 | 500.5 |
Carcinomatosis | 2 | 8.7 | 181.0 |
Other | 34 | 13.0 | 26.2 |
Sarcoidosis | 4 | 11.4 | 54.5 |
Rheumatologic | 2 | 5.7 | 89.0 |
Cardiologic. non-infectious | 2 | 5.7 | 8.0 |
Observation for suspected/other or not specified findings | 8 | 22.9 | 25.9 |
Others (Including: Acute respiratory failure, Fever, unspecified, Hypokalemia, Complications following infusion, transfusion and therapeutic injection, Care involving use of rehabilitation procedure, unspecified, Unspecified multiple injuries, Hypopituitarism, Benign paroxysmal vertigo) | 18 | 52.9 | 15.1 |